The drug’s mechanism of action simultaneously inhibits IL-4 and IL-13, which Sanofi says makes it ... obstructive pulmonary disease (COPD), bullous pemphigoid, prurigo nodularis, chronic hives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback